Last update :
18/03/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Local anesthetic   Lidocaine hydrochloride  
injection
Mouthwash Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Lidocard Finland, Germany
Lidocorit Austria
Lidosen Italy
Linisol Belgium
Pisacaina Colombia, Ecuador, Mexico, Venezuela
Plidocain Poland
Rapidocain Switzerland
Xilina Romania
Xylestesin Austria, Brazil
Xylocain Austria, Canada, Denmark, Finland, Norway, Poland, Sweden, Switzerland
Xylocaina Brazil, Colombia, Ecuador, Italy, Mexico, Portugal
Xylocaine Austria, Belgium, Canada, Egypt, France, Great Britain, Greece, Ireland, Japan, Luxembourg, Malaysia, Morocco, Netherlands, New Zealand, Poland, Saudi Arabia, Slovenia, Tunisia, United Arab Emirates, United States of America
Xylocard Austria, Belgium, Canada, France, Iceland, India, Luxembourg, Netherlands, Saudi Arabia, Sweden
Xylocitin Germany
Xyloneural Austria, Germany, Switzerland
Stability in solutions   injection   Stability in solutions : Lidocaine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0.45 mg/ml 22°C Not specified
21 Day
1126
Level of evidence D
Glass NaCl 0,9% or Glucose 5% 0.45 mg/ml 4°C Protect from light
21 Day
1126
Level of evidence D
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Light
14 Day
619
Level of evidence D
Glass Ringer’s lactate solution 2 mg/ml 25°C Light
14 Day
619
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.45 mg/ml 22°C Not specified
21 Day
1126
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.45 mg/ml 4°C Protect from light
21 Day
1126
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Light
14 Day
619
Level of evidence D
Polyvinyl chloride Glucose 5% 4 mg/ml 30°C Not specified
120 Day
1202
Level of evidence B
Polyvinyl chloride Glucose 5% 4 mg/ml 4°C Protect from light
120 Day
1202
Level of evidence B
Polyvinyl chloride Ringer’s lactate solution 2 mg/ml 25°C Light
14 Day
619
Level of evidence D
Polypropylen Syringe None 20 mg/ml 25°C Light
90 Day
1715
Level of evidence B
Polypropylen Syringe None 20 mg/ml 25°C Light
90 Day
1715
Level of evidence B
Polypropylen Syringe None 20 mg/ml 4°C Protect from light
90 Day
1715
Level of evidence B
  Mentions Légales